Stock investments by politicians have long drawn public scrutiny. Under a 2012 law, members of the U.S. Congress must disclose transactions over a $1,000 threshold. Early in the COVID-19 pandemic, lawmakers on both sides of the aisle were criticized for trading in everything from remote work technologies to telemedicine.
